新型三胺化合物作为5-HT2A激动剂治疗情绪障碍,如抑郁症和双极性障碍
Ram W Sabnis1, Anika R Sabnis2
1Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Suite 1000, Atlanta, Georgia 30309, United States.
ACS medicinal chemistry letters
|March 19, 2025
概括
激活5-HT2A受体的新型试胺化合物显示出治疗情绪障碍的希望. 这些血清素2A (5-HT2A) 激动剂为抑郁症和双相情感障碍提供了新的治疗途径.
科学领域:
- 神经科学是一个神经科学.
- 药用化学 医学化学
- 精神病学是一个精神病学.
背景情况:
- 摘要介绍了新的试胺化合物,其设计是为色素2A (5-HT2A) 受体选择性激动剂.
- 这些化合物正在研究它们在情绪障碍 (包括抑郁症和双相情感障碍) 中的潜在治疗应用.
研究的目的:
- 引入新型的胺化合物,在胺5-HT2A受体上具有特定活性.
- 探索这些化合物在治疗情绪障碍方面的潜在治疗应用.
- 描述制备这些新型胺衍生物的合成过程.
主要方法:
- 新型胺化合物的合成和表征.
- 对5-HT2A受体激素的化合物的药理学评估.
- 在情绪障碍的临床前模型中对化合物的评估 (细节未在摘要中提供).
主要成果:
- 鉴定新型试胺化合物,证明其具有5-HT2A受体agonistic活性.
- 证明这些化合物在制药成分中的实用性.
- 为制备这些化合物建立合成路径.
结论:
- 作为5-HT2A激动剂的新型胺化合物代表了对情绪障碍的有前途的新疗法.
- 这些化合物为抑郁和双相情感障碍提供了潜在的新治疗策略.
- 描述的合成工艺促进了这些新型药物的开发和潜在制造.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
174
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
174
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
262
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
262
Antidepressant Drugs: Overview
343
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
343
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
201
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
201
Sedatives and Hypnotics Drugs: Miscellaneous Agents
138
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
138
Drug Therapy
32
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
32

![Radiosynthesis of 1-2-[18F]Fluoroethyl-L-Tryptophan using a One-pot, Two-step Protocol](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F63025.jpg&w=3840&q=50)
